Requier Florence, Demnitz-King Harriet, Whitfield Tim, Klimecki Olga, Marchant Natalie L, Collette Fabienne
GIGA-CRC In Vivo Imaging, Université de Liège, Bâtiment B30, Allée du Six Août, 8, Sart Tilman, 4000 Liège, Belgium.
Department of Psychology, Cognition and Behavior, University of Liège, Liège, Belgium.
Psychol Belg. 2023 Jun 23;63(1):64-81. doi: 10.5334/pb.1182. eCollection 2023.
Persistent fatigue constitutes a prevalent and debilitating symptom in several diseases. The symptom is not effectively alleviated by pharmaceutical treatments, and meditation has been proposed as a non-pharmacological intervention. Indeed, meditation has been shown to reduce inflammatory/immune problems, pain, stress, anxiety and depression which are associated with pathological fatigue. This review synthesizes data from randomized control trials (RCTs) that explored the effect of meditation-based interventions (MeBIs) on fatigue in pathological conditions. Eight databases were searched from inception to April 2020. Thirty-four RCTs met eligibility criteria and covered six conditions (68% cancer), 32 of which were included in the meta-analysis. The main analysis showed an effect in favor of MeBIs compared to control groups ( = 0.62). Separate moderator analyses assessing control group, pathological condition, and MeBI type, highlighted a significantly moderating role of the control group. Indeed, compared to actively controlled studies, studies using a passive control group were associated with a statistically significantly more beneficial impact of the MeBIs ( = 0.83). These results indicate that MeBIs alleviate pathological fatigue and it seems that the studies with a passive control group showed a greater effect of MeBI on the reduction of fatigue compared to studies using active control groups. However, the specific effect of meditation type and pathological condition should be analyzed with more studies, and there remains a need to assess meditation effects on different types of fatigue (i.e., physical and mental) and in additional conditions (e.g., post-COVID-19).
持续性疲劳是多种疾病中普遍存在且使人虚弱的症状。药物治疗并不能有效缓解该症状,冥想已被提议作为一种非药物干预措施。事实上,冥想已被证明可以减少与病理性疲劳相关的炎症/免疫问题、疼痛、压力、焦虑和抑郁。本综述综合了随机对照试验(RCT)的数据,这些试验探讨了基于冥想的干预措施(MeBIs)对病理性状况下疲劳的影响。从数据库创建到2020年4月,我们搜索了八个数据库。34项RCT符合纳入标准,涵盖六种疾病(68%为癌症),其中32项纳入了荟萃分析。主要分析表明,与对照组相比,MeBIs有效果( = 0.62)。评估对照组、病理状况和MeBI类型的单独调节分析突出了对照组的显著调节作用。事实上,与积极对照研究相比,使用被动对照组的研究中,MeBIs在统计学上具有更显著的有益影响( = 0.83)。这些结果表明,MeBIs可缓解病理性疲劳,与使用积极对照组的研究相比,使用被动对照组的研究中,MeBI对减轻疲劳似乎有更大的效果。然而,冥想类型和病理状况的具体影响需要更多研究进行分析,并且仍有必要评估冥想对不同类型疲劳(即身体和精神疲劳)以及其他状况(如新冠后)的影响。